Cancer specialist elected to Royal College of Medicine

September 04, 2000

NASHVILLE, Tenn. -- Dr. Raymond N. DuBois Jr., associate director for Cancer Prevention at the Vanderbilt-Ingram Cancer Center, has been selected for membership into the Royal College of Physicians, the oldest medical association in the United Kingdom and one of the oldest in the world.

DuBois, Mina Cobb Wallace Professor of Cancer Research, will be formally admitted to the College during a ceremony Nov. 29 in London. He was selected for "admission without examination," which is restricted to a select number of individuals in recognition of their "exceptionally distinguished contributions in the field of medicine," according to Professor Ian Gilmore, registrar of the Royal College.

Only nine members have been elected to the Royal College so far this year, and DuBois is the only American among them.

The Royal College was created in 1518 by royal charter of King Henry VIII and has since been engaged in a variety of activities dedicated to the upholding and improvement of standards in the practice of medicine.

Today, the College includes more than 8,500 fellows, most of them physicians in the United Kingdom, and 6,000 collegiate members worldwide. The College issues reports and recommendations on a variety of issues ranging from practice standards to the impact of tobacco and alcohol on public health.

DuBois, who joined the Vanderbilt faculty in 1991, also serves as director of the division of Gastroenterology. He is an internationally recognized scientist in the field of cancer prevention and specifically the development of colorectal cancer and the potential of aspirin-like drugs to prevent -- and possibly treat -- that and other forms of cancer.

He recently co-chaired the National Cancer Institute's Progress Review Group on Colorectal Cancer, which reviewed and issued recommendations to NCI Director Dr. Richard Klausner on the state of research in the field. He serves as one of seven scientific advisors to the Colorectal Cancer Research Alliance, a nationwide initiative spearheaded by NBC's Katie Couric and fundraiser Lilly Tartikoff to increase awareness of colorectal cancer, promote early detection and raise funds for research.

DuBois is a national co-investigator in a major study now under way to test whether the arthritis drug celocoxib can prevent the formation of precancerous polyps in the colon.

He also serves as the president of the Southern Society for Clinical Investigation, president of the Gastroenterology Research group and associate editor for Cancer Research, the primary journal of the American Association for Cancer Research.
-end-
The Vanderbilt-Ingram Cancer Center is one of a select few designated by the National Cancer Institute to lead the worldwide fight against cancer. Vanderbilt-Ingram is the only NCI-designated cancer center in Tennessee that treats and conducts research in all types of cancer in adults and children. Its team of more than 1,000 doctors, scientists, nurses and others are dedicated to working together to offer the most promising treatment and prevention strategies, built on a strong foundation of basic research. For more information, visit http://www.vanderbiltingram.org.




Vanderbilt University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.